25 June 2020
FLASH continues to prove its unique advantages in healthy tissue sparing with tumour control even in radioresistant cases. The LIGHT system is uniquely suited to application of FLASH at all depths. Currently we are investigating the delivery FLASH dose rates for a wide range of spot sizes. Follow us at upcoming ASTRO for more details!